Ubl Named Next PhRMA President and CEO
Stephen J. Ubl to succeed John J. Castellani as the next president and chief executive officer of PhRMA.
The board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) on Sept. 25, 2015 named Stephen J. Ubl the next president and chief executive officer of the association. He succeeds John J. Castellani, who will be retiring at the end of the year.
Ubl joins PhRMA after more than 10 years as the president and CEO of the Advanced Medical Technology Association where he worked with patient advocacy organizations, providers, and public and private payers. He was a board member of the National Health Council.
Source: Pharmaceutical Research and Manufacturers of America (PhRMA)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
